Regional hyperthermia for high-risk soft tissue sarcoma treatment
The Norwegian Institute of Public Health (NIPHNO)
Record ID 32018001170
English
Authors' objectives:
The assessed technology is regional hyperthermia added to conventional therapies to treat high-risk soft tissue sarcoma. The objective of this rapid relative effectiveness assessment was to collaboratively address the research question: Is the regional application of non-invasive external hyperthermia administered in addition to chemo- and/or radiotherapy more effective and/or safer for oncological patients with high-risk soft tissue sarcoma than radio- and/or chemotherapy alone?
Details
Project Status:
Completed
URL for protocol:
https://eunethta.eu/otca18-final-assessment-report-is-now-available/
Year Published:
2019
URL for published report:
https://eunethta.eu/otca18-final-assessment-report-is-now-available/
Requestor:
HTA agencies
English language abstract:
An English language summary is available
Publication Type:
Rapid Review
MeSH Terms
- Sarcoma
- Antineoplastic Combined Chemotherapy Protocols
- Hyperthermia, Induced
- Neoadjuvant Therapy
- Combined Modality Therapy
Contact
Organisation Name:
European Network for Health Technology Assessment
Contact Email:
eunethta@zinl.nl
Copyright:
CC-BY-NC: You may copy, distribute, display, perform, and modify and use the EUnetHTA work for any purpose other than commercially unless you get your permission first.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.